Statement of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net loss attributable to common shareholders	$ 1,593,985	$ 1,530,946
Adjustments to reconcile net loss to net cash used in operating activities
Amortization (accretion) of investments	(1,317,429)	(3,197,526)
Realized investment gains, net	(4,481,591)	(288,811)
Unrealized trading (gains) losses included in income	71,650	(249,992)
Amortization of deferred policy acquisition costs	369,786	42,324
Amortization of cost of insurance acquired	739,236	798,264
Depreciation	1,116,486	954,827
Net income attributable to noncontrolling interest	484,796	480,342
Charges for mortality and administration of universal life and annuity products	(5,001,163)	(5,171,353)
Interest credited to account balances	3,800,529	3,893,025
Change in accrued investment income	218,680	288,854
Change in reinsurance receivables	628,879	505,768
Change in policy liabilities and accruals	(4,940,058)	(4,680,614)
Change in income taxes receivable (payable)	(485,422)	(3,866,361)
Change in other assets and liabilities, net	2,984,740	3,005,247
Net cash used in operating activities	(4,216,896)	(5,955,060)
Proceeds from investments sold and matured:
Fixed maturities available for sale	20,787,523	27,476,702
Equity securities available for sale	6,303,763	528,114
Trading securities	1,051,502	24,017,415
Mortgage loans	1,762,505	15,094,812
Discounted mortgage loans	3,236,923	6,182,319
Real estate	19,525,094	7,301,330
Policy loans	2,590,935	2,758,116
Proceeds from Short-Term Investments	888,384	0
Total proceeds from investments sold and matured	56,146,629	83,358,808
Cost of investments acquired:
Fixed maturities available for sale	(19,580,517)	(21,602,005)
Equity securities available for sale	(6,554,165)	(8,996,880)
Trading securities	(22,524)	(23,105,651)
Mortgage loans	(1,727,681)	(9,986,840)
Discounted mortgage loans	(611,723)	(1,455,670)
Real estate	(7,111,362)	(9,404,269)
Policy loans	(1,934,852)	(2,204,016)
Short-term investments	(4,982,679)	(25,000)
Total cost of investments acquired	(42,525,503)	(76,780,331)
Sale of property and equipment	(1,600,000)	0
Net cash provided by investing activities	12,021,126	6,578,477
Cash flows from financing activities:
Policyholder contract deposits	4,095,032	4,461,097
Policyholder contract withdrawals	(4,584,472)	(4,056,584)
Proceeds from notes payable/line of credit	1,600,000	0
Payments of principal on notes payable/line of credit	(1,500,000)	(1,857,954)
Purchase of treasury stock	(269,429)	(238,305)
Sale of block of business	(3,045,574)	0
Distributions to minority interests of consolidated subsidiaries	(1,472,522)	0
Net cash provided by (used in) financing activities	(5,176,965)	(1,691,746)
Net increase (decrease) in cash and cash equivalents	2,627,265	(1,068,329)
Cash and cash equivalents at beginning of period	19,838,618	23,321,246
Cash and cash equivalents at end of period	$ 22,465,883	$ 22,252,917